Dapagliflozin Cuts Risk of Worsening Heart Failure
Dapagliflozin reduced the risk of worsening heart failure and death in patients with and without diabetes, a trial in the New England Journal of Medicine found.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cardiology | Dapagliflozin | Diabetes | Endocrinology | Forxiga | General Medicine | Heart | Heart Failure